Grifols Net Income 2012-2018 | GRFS

Grifols annual/quarterly net income history and growth rate from 2012 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Grifols net income for the quarter ending September 30, 2018 was $0.000B, a 100% decline year-over-year.
  • Grifols net income for the twelve months ending September 30, 2018 was $0.510B, a 15.44% decline year-over-year.
  • Grifols annual net income for 2017 was $0.749B, a 24.1% increase from 2016.
  • Grifols annual net income for 2016 was $0.604B, a 2.15% increase from 2015.
  • Grifols annual net income for 2015 was $0.591B, a 4.83% decline from 2014.
Grifols Annual Net Income
(Millions of US $)
2017 $749
2016 $604
2015 $591
2014 $621
2013 $454
2012 $328
2011 $70
Grifols Quarterly Net Income
(Millions of US $)
Q3 2018 $0
Q2 2018 $209
Q2 2017 $158
Q1 2017 $143
Q4 2016 $150
Q3 2016 $158
Q2 2016 $157
Q1 2016 $138
Q4 2015 $144
Q3 2015 $156
Q2 2015 $147
Q1 2015 $145
Q4 2014 $149
Q3 2014 $151
Q2 2014 $139
Q1 2014 $168
Q4 2013 $104
Q3 2013 $112
Q2 2013 $121
Q1 2013 $118
Q4 2012 $76
Q3 2012 $80
Q2 2012 $85
Q1 2012 $87
Q4 2011 $9
Q3 2011 $35
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $14.332B $4.878B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $54.736B 11.72
Zoetis (ZTS) United States $44.432B 30.42
Tilray (TLRY) United States $9.532B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.553B 12.28
Neurocrine Biosciences (NBIX) United States $7.810B 1722.60
Ionis Pharmaceuticals (IONS) United States $6.887B 0.00
Nektar Therapeutics (NKTR) United States $6.517B 9.34
Impax Laboratories (AMRX) United States $5.575B 29.65
Catalent (CTLT) United States $5.510B 23.11
Sage Therapeutics (SAGE) United States $5.066B 0.00
United Therapeutics (UTHR) United States $4.837B 7.91
Loxo Oncology (LOXO) United States $4.391B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.949B 14.62
FibroGen (FGEN) United States $3.356B 0.00
Endo (ENDP) Ireland $2.896B 4.44
USANA Health Sciences (USNA) United States $2.869B 24.42
Madrigal Pharmaceuticals (MDGL) United States $2.212B 0.00
Heron Therapeutics (HRTX) United States $2.146B 0.00
Xencor (XNCR) United States $2.092B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.955B 264.11
Endocyte (ECYT) United States $1.932B 0.00
Aerie Pharmaceuticals (AERI) United States $1.882B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.703B 0.00
Zogenix (ZGNX) United States $1.645B 0.00
PTC Therapeutics (PTCT) United States $1.600B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.460B 17.86
Corcept Therapeutics (CORT) United States $1.436B 21.08
TESARO (TSRO) United States $1.431B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.363B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.328B 0.00
Tricida (TCDA) United States $1.299B 0.00
Portola Pharmaceuticals (PTLA) United States $1.274B 0.00
Esperion Therapeutics (ESPR) United States $1.242B 0.00
TherapeuticsMD (TXMD) United States $1.163B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.062B 0.00
ImmunoGen (IMGN) United States $0.826B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.766B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.691B 0.00
Radius Health (RDUS) United States $0.667B 0.00
Karyopharm Therapeutics (KPTI) United States $0.628B 0.00
Flexion Therapeutics (FLXN) United States $0.614B 0.00
Collegium Pharmaceutical (COLL) United States $0.579B 0.00
GlycoMimetics (GLYC) United States $0.482B 0.00
ChemoCentryx (CCXI) United States $0.462B 36.60
Siga Technologies (SIGA) United States $0.446B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.440B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.433B 0.00
Odonate Therapeutics (ODT) United States $0.428B 0.00
Akebia Therapeutics (AKBA) United States $0.427B 0.00
Xeris Pharmaceuticals (XERS) United States $0.427B 0.00
OptiNose (OPTN) United States $0.424B 0.00
Aquestive Therapeutics (AQST) United States $0.421B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.420B 24.74
Dermira (DERM) United States $0.413B 0.00
ArQule (ARQL) United States $0.404B 0.00
Dova Pharmaceuticals (DOVA) United States $0.398B 0.00
Forty Seven (FTSV) United States $0.389B 0.00
Aclaris Therapeutics (ACRS) United States $0.373B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.373B 0.00
Zafgen (ZFGN) United States $0.364B 0.00
Depomed (ASRT) United States $0.356B 13.24
Verrica Pharmaceuticals (VRCA) United States $0.349B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.336B 0.00
Mast Therapeutics (SVRA) United States $0.325B 0.00
Minerva Neurosciences (NERV) United States $0.322B 0.00
Aratana Therapeutics (PETX) United States $0.312B 0.00
Tapimmune (MRKR) United States $0.311B 0.00
KalVista Pharmaceuticals (KALV) United States $0.289B 0.00
CASI Pharmaceuticals (CASI) United States $0.288B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.288B 0.00
Majesco Entertainment (PTE) United States $0.283B 0.00
Translate Bio (TBIO) United States $0.267B 0.00
Concert Pharmaceuticals (CNCE) United States $0.265B 0.00
IMV INC (IMV) Canada $0.240B 0.00
Opexa Therapeutics (ACER) United States $0.239B 0.00
Affimed (AFMD) Germany $0.237B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.214B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.214B 0.00
Lannett Co Inc (LCI) United States $0.211B 1.84
Ocular Therapeutix (OCUL) United States $0.207B 0.00
Tyme Technologies (TYME) United States $0.207B 0.00
MEI Pharma (MEIP) United States $0.200B 0.00
ElectroCore (ECOR) United States $0.196B 0.00
Neon Therapeutics (NTGN) United States $0.193B 0.00
Galectin Therapeutics (GALT) United States $0.190B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.189B 0.00
Calithera Biosciences (CALA) United States $0.188B 0.00
Aldeyra Therapeutics (ALDX) United States $0.187B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.186B 0.00
Redhill Biopharma (RDHL) Israel $0.177B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.175B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 0.00
Ardelyx (ARDX) United States $0.169B 0.00
ContraFect (CFRX) United States $0.162B 0.00
Molecular Templates (MTEM) United States $0.161B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.153B 0.00
MediWound (MDWD) Israel $0.152B 0.00
DURECT (DRRX) United States $0.145B 0.00
Recro Pharma (REPH) United States $0.141B 0.00
Melinta Therapeutics (MLNT) United States $0.137B 0.00
Champions Oncology (CSBR) United States $0.135B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Jounce Therapeutics (JNCE) United States $0.134B 0.00
Adherex Technologies (FENC) United States $0.134B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.126B 0.00
ProNAi Therapeutics (SRRA) Canada $0.119B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.118B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.109B 0.00
Rafael Holdings (RFL) United States $0.106B 0.00
Cardiome Pharma (CORV) Canada $0.104B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.102B 0.00
CTI BioPharma (CTIC) United States $0.097B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.091B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.090B 0.00
Achaogen (AKAO) United States $0.083B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Infinity Pharmaceuticals (INFI) United States $0.078B 0.00
Iterum Therapeutics (ITRM) Ireland $0.074B 0.00
Otonomy (OTIC) United States $0.072B 0.00
Nivalis Therapeutics (ALPN) United States $0.072B 0.00
BioLineRx (BLRX) Israel $0.071B 0.00
Natural Alternatives (NAII) United States $0.069B 6.83
Immune Design (IMDZ) United States $0.068B 0.00
Novan (NOVN) United States $0.063B 0.00
Forward Pharma (FWP) Denmark $0.062B 0.00
KemPharm (KMPH) United States $0.062B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.062B 38.24
Neos Therapeutics (NEOS) United States $0.061B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.060B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.056B 0.00
Avenue Therapeutics (ATXI) United States $0.053B 0.00
Genocea Biosciences (GNCA) United States $0.050B 0.00
Capnia (SLNO) United States $0.045B 0.00
SCYNEXIS (SCYX) United States $0.042B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.038B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.038B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.037B 0.00
Trillium Therapeutics (TRIL) Canada $0.037B 0.00
Heat Biologics (HTBX) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.88
Lipocine (LPCN) United States $0.032B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
Biomerica (BMRA) United States $0.027B 0.00
IsoRay (ISR) United States $0.026B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
HANCOCK JAFFE (HJLI) United States $0.023B 0.00
NanoViricides (NNVC) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
Onconova Therapeutics (ONTX) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.021B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.021B 0.00
ESSA Pharma (EPIX) Canada $0.020B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.019B 6.95
NovaBay Pharmaceuticals (NBY) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
Aviragen Therapeutics (VXRT) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
Aradigm (ARDM) United States $0.017B 0.00
Shineco (TYHT) China $0.016B 1.65
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
Skyline Medical (AIPT) United States $0.012B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.011B 0.00
Regulus Therapeutics (RGLS) United States $0.011B 0.00
Apricus Biosciences (APRI) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
PharmAthene (ALT) United States $0.006B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.004B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
RXi Pharmaceuticals (RXII) United States $0.001B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00